2025-2034 Growth Prospects of the Catheter-Related Bloodstream Infection Market: Key Trends and Opportunities Analyzed
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Significant is the Anticipated Growth Rate of the Catheter-Related Bloodstream Infection Market from 2025 to 2034?
The market size for catheter-related bloodstream infections has seen considerable growth in the past few years. There is projected growth from $1.53 billion in 2024 to $1.62 billion in 2025, indicating a compound annual growth rate (CAGR) of 6.2%. Factors contributing to the growth during the historic period include the escalating instance of chronic ailments, increased understanding and education, a surge in infections acquired within hospital settings, a growing number of elderly individuals, and improved programs for infection control in hospitals and other healthcare environments.
The catheter-related bloodstream infection market is predicted to experience robust expansion in the coming years. By 2029, it is projected to reach a value of $2.05 billion, expanding at a compound annual growth rate (CAGR) of 6.0%. Key factors contributing to the growth in the projected period include an increase in healthcare-associated infections (hais), heightened awareness and education, development of more comprehensive infection control practices training, growth of healthcare infrastructure, rise in the elderly population, and supportive government policies and initiatives. The forecasted period is expected to see key trends, including advancements in biomaterials, intelligent catheter technology, enhancement of catheter lock solutions through advanced antimicrobial features, sterilization process innovation for catheters, and the introduction of automated flushing systems.
How Are the key drivers Contributing to the Expansion of the Catheter-Related Bloodstream Infection Market?
The upward trend in hospital-acquired infections is anticipated to stimulate the expansion of the catheter-related bloodstream infection market. Hospital-acquired infections, or HAIs, refer to infections that patients develop while undergoing treatment for different diseases in a healthcare environment, typically materializing more than 48 hours after hospitalization. The escalation in such infections can be linked to elements like antimicrobial resistance, subpar infection control protocols, and the patient’s vulnerability. Catheter-related bloodstream infections significantly contribute to the rise of hospital-acquired infections attributable to their intrusive qualities and propensity for microbial colonization, presenting dangers to patients with indwelling catheters. For example, data from the National Library of Medicine, a US-based biomedical library, revealed that in January 2023, the global rate of healthcare-associated infection (HAI) stood at 0.14%, witnessing an annual rise of 0.06%. Consequently, the increasing instances of hospital-acquired infections will prompt the expansion of the catheter-related bloodstream infection market.
Explore Comprehensive Insights Into The Global Catheter-Related Bloodstream Infection Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16646&type=smp
Who Are the Dominant Players Pushing the Boundaries of the Catheter-Related Bloodstream Infection Market?
Major companies operating in the catheter-related bloodstream infection market are:
• Pfizer Inc.
• Johnson & Johnson Services Inc.
• Novartis AG
• 3M Company
• Eli Lilly and Company
How Are Market Trends Revolutionizing the Catheter-Related Bloodstream Infection Industry in Recent Times?
Key players in the catheter-related bloodstream infection market are focusing their efforts on creating advanced catheter lock solutions that can not only prevent infections but also enhance patient outcomes. The catheter lock solution is a fluid that is filled into the catheter to keep infections at bay and to ensure that the catheter remains unobstructed between uses. For instance, in November 2023, CorMedix Inc., a biopharmaceutical firm based in the US that concentrates on the development and commercialization of therapeutic products, secured approval from the US Food and Drug Administration for its DefenCath (taurolidine and heparin) catheter lock solution. This solution was designed specifically for adult patients suffering from kidney failure who are undergoing chronic hemodialysis through a central venous catheter (CVC). The solution, which has antimicrobial and antifungal properties, uses a combination of heparin for anticoagulation and taurolidine for its wide-ranging antimicrobial attributes, and aims to reduce instances of catheter-related bloodstream infections (CRBSIs).
Secure Your Global Catheter-Related Bloodstream Infection Market Report Now for Fast and Efficient Delivery!
How Are the Key Segments of the Catheter-Related Bloodstream Infection Market Impacting Its Expansion and Revenue Streams?
The catheter-related bloodstream infection market covered in this report is segmented –
1) By Treatment: Antibiotic Lock Therapy, Anti-Microbial Agents
2) By Source Of Infection Or Causative Agents: Staphylococcus Aureus, Acinetobacter Baumannii, Escherichia Coli (E. Coli), Klebsiella Pneumoniae (K. Pneumonia), Candida Species (Candida Sp.), Pseudomonas Aeruginosa (P. Aeruginosa), Other Source Of Infection Or Causative Agents
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Antibiotic Lock Therapy: Catheter Lock Solutions (Antibiotic-based), Combination Antibiotic Lock Therapy
2) By Anti-Microbial Agents: Antibiotics, Antifungal Agents, Antiseptic Agents
Which Geographic Areas Are Influencing the Growth of the Catheter-Related Bloodstream Infection Market?
North America was the largest region in the catheter-related bloodstream infection market in 2023. The regions covered in the catheter-related bloodstream infection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Is the Catheter-Related Bloodstream Infection Market Classified and Defined in Market Analysis?
Catheter-related bloodstream infection (CRBSI) is a type of infection that occurs when bacteria or fungi enter the bloodstream through a catheter, a tube inserted into a vein to deliver medications or nutrients. It is a serious healthcare-associated infection that can lead to sepsis and other complications. Prompt diagnosis and treatment are essential to prevent severe outcomes.
Browse Through More Similar Reports By The Business Research Company:
PTA Balloon Catheter Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/pta-balloon-catheter-global-market-report
Intravascular Catheters Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/intravascular-catheters-global-market-report
Intermittent Catheters Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/intermittent-catheters-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
